You just read:

Sobi™ - First Patient Randomised in a Phase 3 Study Evaluating Safety and Efficacy of Anakinra in the Treatment of Still's Disease

News provided by

Swedish Orphan Biovitrum AB

Nov 16, 2017, 02:23 ET